Portal de investigación
PATRONES DE RM CEREBRAL Y MEDULAR EN RELACION CON LA PRESENCIA DE AUTOANTIGENOS NEURONALES RECONOCIDOS POR INMUNOGLOBULINAS M PRESENTES EN EL LIQUIDO CEFALORRAQUIDEO DE PACIENTES DE ESCLEROSIS MULTIPLE.
Datos básicos
- Protocolo:
- MERCK SERONO DR. CASANOVA
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- 2010
- Año de finalización:
- 2015
Documentos
- No hay documentos
Participantes
-
Verónica Martí Alcarria
Investigador Colaborador
-
Bonaventura Casanova Estruch
Investigador Principal
-
Eduardo Beltran Beleña
Doctor
-
Enrique España Gregori
Investigador Colaborador
-
Gracian Garcia Marti
Investigador Colaborador
-
Ángel Alberich Bayarri
Investigador Colaborador
-
Aránzazu Navarré Gimeno
Investigador Colaborador
-
Francisco Carlos Pérez Miralles
Licenciado
-
María Del Carmen Alcalá Vicente
Licenciado
-
Francisco Coret Ferrer
Investigador Colaborador
-
Isabel Boscá Blasco
Investigador Principal
Grupos
-
Infecciones Respiratorias
Investigador Principal
Raúl Méndez Ocaña
-
Investigacion Biomédica en Imagen (GIBI 2-30)
Investigador Principal
Leonor Cerdá Alberich
Financiadores - Promotores
Resultados del Ensayo Clínico
Medical Imaging Processing Architecture on ATMOSPHERE Federated Platform
Blanquer, I; (...); Ribeiro, ALP
Proceedings Paper. 10.5220/0007876705890594. 2019
"Venous cavernous malformation in the infraorbital canal with unusual presentation".
Solaz-Ruiz, M G; (...); Espana-Gregori, E
Article. 10.1016/j.oftale.2025.01.009. 2025
[Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)].
Fernández Ó; (...); Grupo Post-ECTRIMS
Article. 10.33588/rn.5907.2014334. 2014
A Cloud Architecture for the Execution of Medical Imaging Biomarkers
Lopez-Huguet, Sergio; (...); Blanquer, Ignacio
Proceedings Paper. 10.1007/978-3-030-22744-9_10. 2019
A guide to treating gait impairment with prolonged-release fampridine (Fampyra (R)) in patients with multiple sclerosis
Ramio-Torrenta, L; (...); Saiz, A
Review. 10.1016/j.nrl.7015.11.013. 2018
Absceso orbitario tras anestesia peribulbar en mucocele frontoetmoidal.
Pardo-López D; (...); Diaz-Llopis M
Abstract of Published Item. 10.1016/j.oftal.2013.02.009. 2014
Accelerating the Diffusion-Weighted Imaging Biomarker in the clinical practice: comparative study
Torro, FB; (...); Bonmati, LM
Proceedings Paper. 10.1016/j.procs.2017.05.108. 2017
Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI
França M; (...); Pessegueiro Miranda H
Article. 10.1007/s00261-017-1048-0. 2017
Acute calcareous corneal degeneration in a patient with chronic graft-versus-host disease.
Ruiz, Marta Gema Solaz; (...); Gregori, Enrique Espana
Review. 10.22336/rjo.2024.10. 2024
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Muñoz D; (...); Sánchez-Matienzo D
Article. 10.1186/1471-2377-13-82. 2013
Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts.
Vidal-Donet JM; (...); Knecht E
Article. 10.1371/journal.pone.0055526. 2013
Allopurinol partially prevents disuse muscle atrophy in mice and humans
Ferrando, B; (...); Vina, J
Article. 10.1038/s41598-018-21552-1. 2018
An algorithm to predict intrathecal synthesis of IgG with high efficiency
Tortosa-Carreres, Jordi; (...); Casanova, Bonaventura
Meeting Abstract. 2023
An expanded parenchymal CD8+ T cell clone in GABA A receptor encephalitis.
Bracher A; (...); Dornmair K
Article. 10.1002/acn3.50974. 2020
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Forn C; (...); Filippi M
Article. 10.1007/s00221-012-3380-5. 2013
Analysis of factors that determine the diagnostic yield of temporal artery biopsy.
Suelves AM; (...); Díaz-Llopis M
Article. 10.1016/j.oftal.2012.06.027. 2013
Angiofibroma nasofaringeo juvenil con extension orbitaria.
Hervas Ontiveros A; (...); Simal Julian JA
Article. 10.1016/j.oftal.2014.02.010. 2015
Anterior Segment Biometry and Their Correlation with Corneal Biomechanics in Caucasian Children
Bueno-Gimeno, I; (...); Espana-Gregori, E
Article. 10.1080/02713683.2018.1539181. 2019
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
Höftberger R; (...); Saiz A
Article. 10.1177/1352458514555785. 2015
Anti-CD20 monoclonal antibodies in primary progressive multiple sclerosis: a real-life comparative study of rituximab vs. ocrelizumab
Alcala, C.; (...); Casanova, B.
Meeting Abstract. 2021
Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab
Villar, L.; (...); Alvarez-Cermeno, J. C.
Article. 2013
Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy
Aguilar Gonzalez, Marina; (...); Espana Gregori, Enrique
Article. 10.1177/11206721221123779. 2022
Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients
Calvo-Río V; (...); González-Gay MA
Article. 10.1093/rheumatology/keu266. 2014
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia.
Álvarez-Sánchez L; (...); Cháfer-Pericás C
Article. 10.3390/ijms24021226. 2023
Assessment of the effectiveness and safety of natalizumab for treating relapsing-remitting multiple sclerosis.
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.farma.2010.02.003. 2011
Assessment of the in vivo formation of biofilm on external ventricular drainages.
Ramírez P; (...); Bonastre J
Article. 10.1007/s10096-013-1895-8. 2013
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Espiño M; (...); Villar LM
Article. 10.1016/j.cca.2014.08.004. 2015
Association between Tomographic Characteristics of Pterygium and Preoperative Anterior and Posterior Topography Measured by Anterior Segment Optical Coherence Tomography
Aguilar-Gonzalez, Marina; (...); Peris-Martinez, Cristina
Article. 10.3390/life14101245. 2024
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal, Enric; (...); Villar LM
Article. 10.1001/jamaneurol.2023.0010. 2023
Atypical periodic alternating nystagmus responding to high-dose intravenous immunoglobulins: a case report
Argente-Escrig, H; (...); Casanova Estruch B
Article. 10.1186/s12974-017-0846-1. 2017
Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Burman, J; (...); Farge, D
Article. 10.1038/bmt.2017.40. 2017
Autologous hematopoietic stem cell transplantation in multiple sclerosis: updating outcomes in the Valencian cohort.
Boix Lago, A.; (...); Casanova Estruch, B.
Meeting Abstract. 2023
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
Casanova, B; (...); Coret, F
Article. 10.1007/s10072-017-2933-6. 2017
Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images
Sanz-Requena, R; (...); Ferrer, A
Article. 10.1002/jmri.24805. 2015
Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
Mathur, D; (...); Lopez-Rodas, G
Article. 10.3389/fncel.2017.00209. 2017
Biomarkers in multiple sclerosis: an update for 2014
Fernandez O; (...); Montalban X
Review. 10.33588/rn.5812.2014247. 2014
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
Magraner MJ; (...); Casanova B
Article. 10.1007/s00234-011-0841-7. 2012
Brain atrophy in relapsing optic neuritis is associated to anti-mog antibodies
Navarro Canto, L.; (...); Casanova Estruch, B.
Meeting Abstract. 2019
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.
Perez-Miralles, Francisco Carlos; (...); Casanova, Bonaventura
Article. 10.1002/brb3.2044. 2021
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects
Mathur D; (...); Burgal-Marti M
Article. 10.3389/fncel.2015.00375. 2015
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
Quintanilla-Bordás C; (...); Casanova B
Article. 10.3389/fneur.2022.897275. 2022
Cerebrospinal fluid kappa free light chains and IgM index for diagnosis and prognosis in multiple sclerosis
Gil-Perotin, S.; (...); Casanova, B.
Meeting Abstract. 2021
Cervical spinal cord T2 lesions independently predict early conversion to secondary progressive multiple sclerosis: a longitudinal 10-year study
Lacruz-Ballester, L.; (...); Casanova-Estruch, B.
Meeting Abstract. 2021
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study
Oreja-Guevara, Celia; (...); Rio, Jordi
Article. 10.1016/j.msard.2024.105787. 2024
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical experience with rituximab in the treatment of refractory multiple sclerosis
Gascon, F.; (...); Coret, F.
Meeting Abstract. 2014
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Clinical impact of early brain atrophy in clinically isolated syndromes.
Pérez-Miralles F; (...); Montalban X
Article. 10.1177/1352458513488231. 2013
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels
Quintanilla-Bordas, Carlos; (...); Casanova, Bonaventura
Article. 10.3389/fneur.2024.1477335. 2024
Clinical, demographic and laboratory data associated with PML risk in patients treated with natalizumab
Toboso, I; (...); Villar, LM
Meeting Abstract. 2017
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
Gil-Perotin S; (...); Casanova B
Article. 10.3389/fneur.2019.01008. 2019
Comorbilidad en esclerosis multiple y su abordaje asistencial.
Abstract of Published Item. 10.1016/S0025-7753(15)30004-X. 2014
Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients
Gasque-Rubio, Raquel; (...); Perez-Miralles, Francisco
Article. 10.1155/2024/1950913. 2024
Consensus document on spasticity in patients with multiple sclerosis
Oreja-Guevara, Celia; (...); Fernandez, Oscar
Article. 10.33588/rn.5708.2013374. 2013
Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; (...); López-Fando L
Article. 10.1002/nau.24276. 2020
Consensus guidelines for the timely detection and diagnosis of disease progression in multiple sclerosis patients
Oreja-Guevara, C; (...); Meca-Lallana, J
Meeting Abstract. 2020
Consensus on early detection of disease progression in patients with multiple sclerosis
Meca-Lallana, Jose E.; (...); Oreja-Guevara, Celia
Article. 10.3389/fneur.2022.931014. 2022
Corneal Biomechanical Parameters With Corneoscleral Contact Lenses in Post-Laser In Situ Keratomileusis Eyes
Montalt, JC; (...); Peris-Martinez, C
Article. 10.1097/ICL.0000000000000420. 2018
Corneal Biomechanics, Retinal Nerve Fiber Layer, and Optic Disc in Children
Bueno-Gimeno, I; (...); Espana-Gregori, E
Article. 10.1097/OPX.0000000000000406. 2014
Corneo-scleral contact lens in a piggyback system for keratoconus: A case report
Porcar, Esteban; (...); Peris-Martinez, Cristina
Article. 10.1016/j.clae.2016.12.007. 2017
Corneoscleral contact lenses fitting on irregular corneas after laser-assisted in situ keratomileusis
Montalt, JC; (...); Peris-Martinez, C
Article. 10.5935/0004-2749.20180061. 2018
Corneoscleral contact lenses for visual rehabilitation after keratoplasty surgery.
Montalt JC; (...); Peris-Martínez C
Article. 10.1016/j.clae.2020.04.009. 2020
Corneo-scleral contact lenses in an uncommon case of keratoconus with high hyperopia and astigmatism
Porcar, E; (...); Peris-Martinez, C
Article. 10.1016/j.clae.2017.07.004. 2017
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA A receptor encephalitis.
Brändle SM; (...); Dornmair K
Article. 10.1073/pnas.1916337118. 2021
CSF chitinase 3-like-1 association with disability of primary progressive MS
Perez-Miralles, F; (...); Casanova, B
Article. 10.1212/NXI.0000000000000815. 2020
Cytokines profile in the cerebrospinal fluid in chronic relapsing inflammatory demyelinating diseases of the central nervous system
Simo-Castello, M.; (...); Coret, F.
Meeting Abstract. 2014
Changes in Brain Volume in Specific Regions could be related to Disability Progression in Primary Progressive Multiple Sclerosis Patients
Miralles, FP; (...); Casanova, B
Meeting Abstract. 2019
Changes in brain volume in specific regions could predict worsening cognition in primary progressive multiple sclerosis
Perez-Miralles, F; (...); Casanova, B
Meeting Abstract. 2019
Characterization of Bone Microarchitecture Extracted from MR and MDCT. Feature Analysis Validated Against a Synthetic Trabecular Bone Phantom
Ten-Esteve, A; (...); Alberich-Bayarri, A
Proceedings Paper. 10.1007/978-3-319-68195-5_71. 2018
Characterization of individual IgM oligoclonal band antibodies from the cerebrospinal fluid (CSF) of multiple sclerosis patients to identify their antigens
Beltran, E.; (...); Dornmair, K.
Article. 2013
Characterization of the gait in patients with relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis measured by FeetMe (R) integrated sensor insole system: Results of the interim analysis
Izquierdo Ayuso, G.; (...); Casanova Estruch, B.
Meeting Abstract. 2021
Chitinase-3-like protein 1 could be a predictor of disability progression in patients with primary progressive multiple sclerosis
Perez-Miralles, F; (...); Casanova, B
Meeting Abstract. 2018
Chitinase-3-like protein 1 could be a predictor of disability progression in patients with primary progressive multiple sclerosis: A one-year follow-up
Perez-Miralles, F; (...); Casanova, B
Meeting Abstract. 2019
Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: reversal by anti-tnfa treatment.
Balzano T; (...); Felipo V
Article. 10.1016/j.jhep.2019.01.008. 2020
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade
Ribes García S; (...); Casanova Estruch B
Article. 10.1159/000446580. 2016
Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.
Barreiro-Gonzalez, Antonio; (...); Casanova, Bonaventura
Article. 10.1159/000519772. 2022
Development of imaging biomarkers and generation of big data
Alberich-Bayarri, A; (...); Marti-Bonmati, L
Article. 10.1007/s11547-017-0742-x. 2017
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study.
Ramírez P; (...); Ramírez P
Article. 10.1186/cc10015. 2011
Difference in Regional Brain Volume between Fibromyalgia Patients and Long-Term Meditators
Fayed, Nicolas; (...); Garcia-Campayo, Javier
Article. 2017
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients
Casanova, B; (...); Coret, F
Article. 10.1007/s10072-018-3442-y. 2018
Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke
Puig, J; (...); Pedraza, S
Review. 10.1007/s00234-017-1816-0. 2017
DISCOVER STUDY, FIRST ANALYSIS SPECIFIC FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS BURDEN AND COST IN SPAIN: INTERIM ANALYSIS RESULTS
Oreja-Guevara, C; (...); Meca-Lallana, J
Meeting Abstract. 2020
Discrete particle model for cement infiltration within open-cell structures: Prevention of osteoporotic fracture
Ramos-Infante, SJ; (...); Perez, MA
Article. 10.1371/journal.pone.0199035. 2018
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.
Brieva, Luis; (...); Moral, Ester
Article. 10.1016/j.msard.2022.103805. 2022
Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects
Mathur, D; (...); Burgal-Marti, M
Article. 10.3390/brainsci8010001. 2018
Documento de consenso sobre la espasticidad en pacientes con esclerosis multiple.
Oreja-Guevara C; (...); Fernández Ó
Abstract of Published Item. 10.33588/rn.5708.2013374. 2013
Does benign multiple sclerosis exist?
Verdini Martinez, Laura; (...); Casanova, Bonaventura
Meeting Abstract. 2023
Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis
Aguilar-González M; (...); Pérez-López M
Article. 10.1111/jocd.15014. 2022
Doppler ultrasound and giant cell arteritis.
Suelves AM; (...); Díaz-Llopis M
Article. 10.2147/OPTH.S13006. 2010
Dynamic 18F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study
Quintanilla Bordas, Carlos; (...); Casanova, Bonaventura
Meeting Abstract. 2023
Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness
Sanz-Requena, R; (...); Garcia-Marti, G
Article. 10.1016/j.ejrad.2016.09.022. 2016
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
Barreiro-González A; (...); Casanova B
Article. 10.1007/s13760-020-01516-x. 2020
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms241814151. 2023
Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study.
Meca-Lallana, J E; (...); Calles Hernandez, C
Article. 10.1016/j.nrleng.2021.06.006. 2023
Early beginning of alemtuzumab: changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study
Meca-Lallana, J. E.; (...); Hernandez, C. Calles
Article. 10.1016/j.nrl.2021.06.007. 2024
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases
Megias-Vericat, JE; (...); Poveda, JL
Review. 10.1007/s10072-017-2833-9. 2017
Economic impact and clinical profile of the secondary progressive multiple sclerosis (SPMS) patient: the DISCOVER study
Oreja-Guevara, C.; (...); Meca-Lallana, J. E.
Meeting Abstract. 2021
Economic impact of the secondary progressive multiple sclerosis in spain: interim analysis of the discover study
Oreja-Guevara, C; (...); Meca-Lallana, J
Meeting Abstract. 2020
Eculizumab for a catastrophic relapse in NMOSD: case report.
Gorriz, David; (...); Casanova, Bonaventura
Article. 10.1007/s10072-023-06971-x. 2023
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana JE; (...); Llarena C
Article. 10.1007/s40120-023-00557-7. 2023
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
Alcala, Carmen; (...); Casanova, Bonaventura
Article. 10.1007/s00415-022-10989-0. 2022
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Villoslada P; (...); NeuroAdvan study
Article. 10.1212/NXI.0000000000000147. 2015
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
Alcala, C; (...); Casanova, B
Article. 10.1007/s00415-018-8899-3. 2018
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
Perez-Moreiras, JV; (...); Tocilizumab Graves Orbitopathy Stu
Article. 10.1016/j.ajo.2018.07.038. 2018
Elevation of Chi3l1 in acute disseminated encephalomyelitis: implications in pathogenesis
Gil-Perotin, S; (...); Casanova-Estruch, B
Meeting Abstract. 2018
Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report.
Quintanilla-Bordás C; (...); Pérez-Miralles FC
Case Reports. 10.3389/fimmu.2024.1465678. 2024
Escalation vs. Early Intense Therapy in Multiple Sclerosis.
Casanova, Bonaventura, Quintanilla-Bordas, Carlos, Gascon, Francisco
Article. 10.3390/jpm12010119. 2022
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
Tortosa-Carreres J; (...); Pérez-Miralles FC
Article. 10.1016/j.jneuroim.2024.578428. 2024
Evaluation of a novel software application for magnetic resonance distortion correction in cranial stereotactic radiosurgery
Calvo-Ortega JF; (...); Casals J
Article. 10.1016/j.meddos.2018.04.002. 2019
Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging
França M; (...); Miranda HP
Article. 10.1007/s00261-016-0899-0. 2017
Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method
Carles, M; (...); Marti-Bonmati, L
Article. 10.1088/1361-6560/62/2/652. 2017
Fingolimod plus steroids prevents return to clinical activity after natalizumab withdrawal
Alcala, C.; (...); Casanova, B.
Article. 2013
Fitting Scleral Lenses Less Than 15 mm in Diameter: A Review of the Literature.
Porcar E; (...); Peris-Martínez C
Review. 10.1097/ICL.0000000000000647. 2020
Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study.
Forn C; (...); Filippi M
Article. 10.1177/1352458511417744. 2012
Geographic atrophy: Etiopathogenesis and current therapies.
Sastre-Ibanez M; (...); Garcia-Armendariz B
Article. 10.1016/j.oftal.2017.07.004. 2018
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
Castillo-Villalba, Jessica; (...); Casanova, Bonaventura
Article. 10.3389/fimmu.2022.827738. 2022
High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study
Puig J; (...); Pedraza S
Article. 10.1007/s00234-015-1599-0. 2016
How to integrate quantitative information into imaging reports for oncologic patients.
Marti-Bonmati, L; (...); Alberich-Bayarri, A
Article. 10.1016/j.rx.2018.02.005. 2018
Identifying pulmonary nodules or masses on chest radiography using deep learning: external validation and strategies to improve clinical practice.
Liang CH; (...); Wu FZ
Article. 10.1016/j.crad.2019.08.005. 2020
IgG4-related dacryocystitis and aortitis: A new association.
España-Gregori E; (...); Aguilar-González M
Editorial Material. 10.1177/1120672118823123. 2020
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Zubizarreta, I; (...); Villoslada, P
Article. 10.1073/pnas.1820039116. 2019
Immune tolerance in patients with Multiple Sclerosis and Neuromyelitis Optica by peptide-loaded tolerogenic dendritic cells: final results of the phase 1b clinical trial and extension
Zubizarreta, I; (...); Villoslada, P
Meeting Abstract. 2019
Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis
Villar LM; (...); Bar-Or A
Article. 10.1002/ana.24190. 2014
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis
Edo Solsona MD; (...); Poveda Andrés JL
Article. 10.2147/PPA.S127508. 2017
IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.; (...); Poveda-Andres, J.
Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016
Impact of Corneoscleral Contact Lens Usage on Corneal Biomechanical Parameters in Keratoconic Eyes.
Porcar E; (...); Peris-Martínez C
Article. 10.1097/ICL.0000000000000579. 2019
Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia
Lopez-Ferraz C; (...); Torres A
Article. 10.1016/j.jinf.2014.05.011. 2014
Impact of stigma in patients with primary progressive multiple sclerosis: a one-year follow-up
Perez-Miralles, F; (...); Casanova, B
Meeting Abstract. 2019
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept.
Gil-Perotin S; (...); Bonastre J
Article. 10.1186/cc11357. 2012
Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study
Meca Lallana, Jose; (...); Forner, Mireia
Meeting Abstract. 10.1212/WNL.0000000000202381. 2023
Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study.
Meca-Lallana, Jose Eustasio; (...); Toledo, Baldo
Article. 10.1186/s41687-024-00822-9. 2024
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.
Tortosa-Carreres J; (...); Pérez-Miralles FC
Article. 10.1016/j.msard.2023.104997. 2023
In Situ RT-PCR Optimized For Electron Microscopy Allows Description Of Subcellular Morphology Of Target mRNA-Expressing Cells In the Brain
LAURA CUBAS NÚÑEZ; (...); Gil-Perotin S
Article. 2017
In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
Cubas-Nunez, L; (...); Gil-Perotin, S
Article. 10.3389/fncel.2017.00141. 2017
Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema.
Udaondo Mirete P; (...); Espana-Gregori, Enrique
Article. 10.3390/jcm12010348. 2023
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
Beltrán E; (...); Dornmair K
Article. 10.1093/brain/awu205. 2014
Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma
Puig J; (...); Pedraza S
Article. 10.1371/journal.pone.0158887. 2016
La elastografia mediante tecnica Acoustic radiation force impulse es eficaz en la deteccion de fibrosis hepatica en el nino.
Aliaga, SDP; (...); Marti-Bonmati, L
Article. 10.1016/j.rx.2014.04.005. 2015
Leptomeningeal gadolinium enhancement in multiple sclerosis
Gascon-Gimenez, F; (...); Casanova, V
Meeting Abstract. 2019
Leptomeningeal gadolinium enhancement lesions in multiple sclerosis are not related to different brain volume measures
Garcia, F; (...); Casanova, B
Meeting Abstract. 2018
Letter to the editor concerning "A new approach to corpus callosum anomalies in idiopathic scoliosis using diffusion tensor magnetic resonance imaging" by Joly O et al. (2014) Eur Spine J 23:2643-9
Domenech J; (...); Garcia-Marti G
Letter. 10.1007/s00586-016-4453-0. 2016
Lipid-specific IgM oligoclonal bands in clinically isolated syndrome: 5-years follow-up
Molla, B.; (...); Casanova, B.
Meeting Abstract. 2014
Lipid-Specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy during Treatment with Natalizumab
Villar LM; (...); Álvarez-Cermeño JC
Article. 10.1002/ana.24345. 2015
Lipid-specific oligoclonal IgM bands: is there any influence on the response to treatment with fingolimod?
Perez-Romero, L.; (...); Casanova, B.
Meeting Abstract. 2014
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic review
Gonzalez-Vivas, C; (...); Sanjuan, J
Review. 10.1016/j.eurpsy.2019.04.009. 2019
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Frasquet M; (...); Casanova B
Article. 10.1016/j.jneuroim.2013.07.003. 2013
Long-term efficacy of alemtuzumab in multiple sclerosis: a real word multicenter Spanish experience
Rubio Alcantud, Almudena; (...); Casanova, Bonaventura
Meeting Abstract. 2023
Long-term treatment effect over disability progression in patients with relapsing multiple sclerosis
Estruch, BC; (...); Coret, F
Meeting Abstract. 2017
Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance
Puig J; (...); Fernandez-Real JM
Article. 10.1111/cen.12954. 2016
Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.
Barreiro-González A; (...); Casanova B
Article. 10.1016/j.jns.2020.117180. 2020
Magnetic resonance imaging as an assessment tool following intervention with an AdVance XP suburethral sling for postprostatectomy urinary incontinence
Serra, AC; (...); Rubio-Briones, J
Article. 10.1002/nau.24023. 2019
Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.
Hervás Ontiveros A; (...); Díaz-Llopis M
Article. 10.1016/j.oftal.2013.10.009. 2014
Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview
Garcia-Foncillas, J; (...); Gomez, MVP
Review. 10.1007/s40291-021-00544-4. 2021
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Munoz-San Martin, Maria; (...); Ramio-Torrenta, Lluis
Article. 10.1212/NXI.0000000000200069. 2023
Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
Burguera-Gimenez, N; (...); Jonna, G
Article. 10.2147/OPTH.S246245. 2020
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors
Haines JD; (...); Lopez-Rodas G
Article. 10.1177/1352458515573094. 2015
Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance
Moreno-Navarrete, JM; (...); Fernandez-Real, JM
Article. 10.1038/ijo.2017.162. 2017
Neuromyelitis optica spectrum disorders Comparison according to the phenotype and serostatus
Sepúlveda M; (...); Saiz A
Article. 10.1212/NXI.0000000000000225. 2016
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Beltrán E; (...); Casanova B
Article. 10.1016/j.jneuroim.2012.03.013. 2012
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Toboso I; (...); Villar LM
Article. 10.3389/fneur.2020.579438. 2020
NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity.
Alcala, C.; (...); Casanova, B.
Article. 10.1007/s00415-021-10926-7. 2022
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.
Alcala Vicente, Carmen; (...); Casanova, Bonaventura
Article. 10.3389/fneur.2022.991596. 2022
Oligoclonal M bands distinguish two MS populations based on neurofilament light chain levels in patients without inflammatory activity
Castillo, J.; (...); Casanova, B.
Meeting Abstract. 2022
Oligoclonal M bands unveil occult inflammation in multiple sclerosis.
Casanova B; (...); Pérez-Miralles F
Article. 10.1016/j.msard.2022.104118. 2022
One-year follow-up optical coherence tomography in clinically isolated syndrome
Bosca, I.; (...); Casanova, B.
Article. 2011
Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.
Coret F; (...); Casanova B
Article. 10.1177/2055217318783347. 2018
Optic nerve melanocytoma.
Gallego-Pinazo R; (...); Espana-Gregori E
Article. 10.1016/j.oftal.2016.05.014. 2016
Optical Coherence Tomography Characterization of Macular Changes Secondary to Arteriovenous Fistula
Pascual-Camps, I; (...); Espana-Gregori, E
Article. 10.1080/01658107.2017.1371768. 2018
Optimisation of ultrasound liver perfusion through a digital reference object and analysis tool.
Alberich-Bayarri Á; (...); Martí-Bonmatí L
Article. 10.1186/s41747-019-0086-5. 2019
Optimizing the management of hereditary haemochromatosis: the value of MRI R2*quantification to predict and monitor body iron stores
Franca, M; (...); Porto, G
Letter. 10.1111/bjh.14982. 2018
Orbital involvement by non-Hodgkin lymphoma NK T cells.
Hervás-Ontiveros A; (...); Díaz-Llopis M
Article. 10.1016/j.oftal.2013.10.006. 2014
Parametric finite element model of medial patellofemoral ligament reconstruction model development and clinical validation.
Sanchis-Alfonso V; (...); Pérez MA
Article. 10.1186/s40634-019-0200-x. 2019
Perception of stigma in patients with primary progressive multiple sclerosis.
Pérez-Miralles F; (...); Casanova-Estruch B
Article. 10.1177/2055217319852717. 2019
Perception of stigma in people with neuromyelitis optica spectrum disorders (PERSPECTIVES-NMO Study)
Lallana, Jose Meca; (...); Maurino, Jorge
Meeting Abstract. 2021
Periorbital necrotising fasciitis secondary to scratching.
Placinta IA; (...); Bort-Martí MÁ
Article. 10.1016/j.oftal.2019.01.005. 2019
Peripapillary capillary network in dominant optic atrophy linked to OPA1 gene
Rahhal-Ortuno, Miriam; (...); Espana-Gregori, Enrique
Article. 10.1177/11206721211044846. 2021
Peripapillary retinal nerve fibre layer correlates better with spinal cord volume than with brain parenchymal fraction in multiple sclerosis
Barreiro-Gonzalez, A; (...); Casanova, B
Meeting Abstract. 2019
Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis.
Mathur D; (...); Marti MB
Article. 10.3389/fneur.2014.00250. 2014
Posterior Capsular Opacification and Glistening in Hydrophobic Monofocal Biaspheric Intraocular Lens Two Years After Implantation: A Case Control Study
Hervas-Ontiveros, Ana; (...); Cervino, Alejandro
Article. 10.1155/joph/3520219. 2024
Posterior ocular involvement in Behçet's disease and thrombophilic mutations.
Vayá A; (...); Ricart JM
Article. 10.3233/CH-2012-1548. 2012
Posterior scleral perforation due to endogenous endophthalmitis in a pregnant with selective IgA deficiency.
Aguilar-González M; (...); Espana-Gregori, Enrique
Article. 10.22336/rjo.2022.19. 2022
Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma
Sanz-Requena, R; (...); Marti-Bonmati, L
Article. 10.1007/s00330-016-4699-2. 2017
Potential Biomarkers Associated with Multiple Sclerosis Pathology.
Mathur, Deepali; (...); Casanova, Bonaventura
Article. 10.3390/ijms221910323. 2021
Potential Role of CHI3L1+ Astrocytes in Progression in MS.
Cubas-Núñez L; (...); Casanova B
Article. 10.1212/NXI.0000000000000972. 2021
Pourfour du Petit syndrome associated with a cervical vertebral anomaly.
Marín-Lambíes C; (...); Díaz-Llopis M
Article. 10.1097/WNO.0b013e3182625212. 2012
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.
Tortosa-Carreres J; (...); Pérez-Miralles FC
Article. 10.1016/j.msard.2024.105734. 2024
Predictive value of early brain atrophy on response in patients treated with interferon ß.
Pérez-Miralles FC; (...); Montalban X
Article. 10.1212/NXI.0000000000000132. 2015
Predictive value of isolated CSF NfL and Chi3l1 measures in clinical practice
Gil-Perotin, S; (...); Casanova-Estruch, B
Meeting Abstract. 2018
Prognostic Value of Radiomics Signature By Diagnostic 18F-FDG PET/CT Analysis in Aggressive Non-Hodgkin's Lymphoma
Lores, BF; (...); Terol, MJ
Meeting Abstract. 10.1182/blood-2018-99-119851. 2018
Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
Gil-Perotin, S; (...); Casanova-Estruch, B
Article. 10.3389/fneur.2018.00340. 2018
Proptosis as initial manifestation of Burkitt's lymphoma with orbital involvement.
de Freytas A, Rengel Ruiz M, Espana Gregori E
Article. 10.1016/j.oftal.2016.10.002. 2017
Prospective Study: Utility of Anterior Segment Optical Coherence Tomography to Identify Predictive Factors of Recurrence in Pterygium Surgery.
Aguilar-Gonzalez, Marina; (...); Peris-Martinez, Cristina
Article. 10.3390/jcm13164769. 2024
Purtscher-like retinopathy following carotid angioplasty and stenting in the treatment of severe carotid stenosis.
Solaz-Ruiz, M G; (...); Espana-Gregori, E
Article. 10.1177/11206721231204632. 2023
Quantifying the patient's perspective in neuromyelitis optica spectrum disorders: design of a multicenter, non-interventional study
Meca-Lallana, J; (...); Maurino, J
Meeting Abstract. 2020
Quantitative structural analysis of trabecular alveolar bone in the mandible by multidetector computed tomography: differences according to tooth presence and type
Sanz-Requena, R; (...); Marti-Bonmati, L
Article. 10.1016/j.rx.2019.01.003. 2019
Rabdomiosarcoma alveolar orbitario enmascarado por sinusitis etmoidal en un adulto de 25 anos.
Sanz-Marco E; (...); Díaz-Llopis M
Abstract of Published Item. 10.1016/j.oftal.2012.10.012. 2014
Rapid-onset voriconazole-induced cicatricial ectropion.
Pérez-López M; (...); Espana-Gregori, E
Article. 10.1016/j.jfo.2021.06.029. 2022
Recambio plasmático terapéutico: aplicaciones en neurología.
Láinez-Andrés JM; (...); Santonja JM
Abstract of Published Item. 10.33588/rn.6003.2014393. 2015
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.
Ramo-Tello, Cristina; (...); Rovira À
Article. 10.3390/jpm12010006. 2021
Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
Alcala, C; (...); Casanova, B
Editorial Material. 10.1016/j.msard.2018.12.005. 2019
Relapsing inflammatory optic neuropathy: clinical description in a serie of 16 patients
Navarro, L.; (...); Casanova, B.
Meeting Abstract. 2014
Relationship among Corneal Biomechanics, Refractive Error, and Axial Length
Bueno-Gimeno I; (...); Pinero-Llorens DP
Article. 10.1097/OPX.0000000000000231. 2014
Relationship between different cerebrospinal fluid biomarkers in multiple sclerosis: meaning and use in clinical practice
Castillo, J; (...); Casanova, B
Meeting Abstract. 2017
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.
Tortosa-Carreres, Jordi; (...); Perez-Miralles, Francisco
Article. 10.1007/s10072-024-07772-6. 2024
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands
Bosca, I.; (...); Casanova, B.
Article. 10.1177/1352458510371961. 2010
Resting-State Functional Connectivity Magnetic Resonance Imaging and Outcome After Acute Stroke
Puig, J; (...); Pedraza, S
Article. 10.1161/STROKEAHA.118.021319. 2018
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)
Fernandez, Oscar; (...); Tintore, Mar
Article. 10.33588/rn.6105.2015228. 2015
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II)
Fernandez O; (...); Grupo Post-Ectrims GP
Article. 10.33588/rn.6106.2015239. 2015
Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I)
Fernandez, O; (...); Rodriguez-Antiguedad, A
Review. 10.33588/rn.6501.2017168. 2017
Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II)
Fernandez, Oscar; (...); Rodriguez-Antiguedad, Alfredo
Review. 10.33588/rn.6502.2017169. 2017
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Fernández Ó; (...); Post-ECTRIMS group
Article. 10.33588/rn.5411.2012204. 2012
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Fernandez O; (...); Post-ECTRIMS group
Article. 10.33588/rn.5412.2012205. 2012
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Fernández Ó; (...); Grupo Post-ECTRIMS
Article. 10.33588/rn.5705.2013270. 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Fernandez O; (...); Grupo Post-Ectrims GP
Article. 10.33588/rn.5706.2013276. 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Fernández Ó; (...); Post-ECTRIMS Group
Article. 10.33588/rn.5707.2013277. 2013
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)
Fernandez O; (...); Grupo Post-Ectrims GP
Article. 10.33588/rn.5906.2014321. 2014
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
Fernandez, Oscar; (...); Rodriguez-Antigueedad, Alfredo
Article. 10.33588/rn.5907.2014334. 2014
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)
Fernández Ó; (...); Grupo Post-ECTRIMS
Article. 10.33588/rn.5908.2014335. 2014
Revision de las novedades del congreso conjunto ECTRIMS-ACTRIMS 2014, presentadas en la VII Reunion Post-ECTRIMS (I).
Fernandez O; (...); Grupo Post-Ectrims GP
Abstract of Published Item. 10.33588/rn.6105.2015228. 2015
Revision de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunion Post-ECTRIMS (II).
Fernandez O; (...); Rodriguez-Antiguedad A
Article. 10.33588/rn.6502.2017169. 2017
Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality.
Reyes S; (...); Menéndez R
Article. 10.1016/j.rmed.2011.04.011. 2011
Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies
Alcala, C; (...); Casanova, B
Meeting Abstract. 2017
Safety profile and practical considerations of monoclonal antibody treatment.
Article. 10.1016/j.nrl.2011.02.004. 2013
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Monreal E; (...); Villar LM
Article. 10.1093/brain/awae260. 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels at Disease Onset for Prediction of the Risk of Disability Worsening in Patients with Multiple Sclerosis
Monreal, Enric; (...); Villar Guimerans, Luisa Maria
Meeting Abstract. 2023
Serum neurofilament light chain and glial fibrillary acidic protein levels at disease onset unveil immunological pathways of disability acquisition in multiple sclerosis
Monreal, Enric; (...); Villar Guimerans, Luisa Maria
Meeting Abstract. 2024
Serum Neurofilament Light Chain is a surrogate marker of NEDA-3 in Multiple Sclerosis
Gascon Gimenez, Francisco Guillermo; (...); Casanova, Bonaventura
Meeting Abstract. 2023
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).
Pérez-Miralles F; (...); Casanova B
Article. 10.1016/j.msard.2021.102860. 2021
Silent Progression or Bout Onset Progressive Multiple Sclerosis?
Gil-Perotin, S; (...); Casanova, B
Letter. 10.1002/ana.25537. 2019
Somatic hypermutation of intrathecal IgM-producing B cells in multiple sclerosis patients
Beltran, Eduardo; (...); Casanova, Bonaventura
Article. 2012
Spanish registry of multiple sclerosis patients on glatiramer acetate 40 mg/ml treatment: Real-world results and baseline characteristics of initial patients
Fernandez, O; (...); Sanchez-de la Rosa, R
Meeting Abstract. 2017
Spanish Registry of patients with multiple sclerosis treated with fingolimod (GILENYA Registry): safety and effectiveness after one year on treatment
Rodriguez-Antigueedad, A.; (...); Fernandez, O.
Article. 2014
State-of-the-art of bone marrow imaging in multiple myeloma
Marti-Bonmati L; (...); Ruiz-Llorca C
Review. 10.1097/CCO.0000000000000230. 2015
Straatsma Syndrome and cataract: case report and review of the literature.
Blanca, Casado-Pelaez; (...); Enrique, Espana-Gregori
Review. 10.22336/rjo.2023.67. 2023
Stress-Based Femur Fracture Risk Evaluation from Bone Densitometry
Nadal, E; (...); Marti-Bonmati, L
Proceedings Paper. 10.1007/978-3-319-68195-5_70. 2018
Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-?B pathway.
Balzano T; (...); Felipo V
Article. 10.1186/s12974-020-01746-z. 2020
Symptomatic accommodative and binocular dysfunctions from the use of flat-panel displays
Porcar, E; (...); Espana-Gregori, E
Article. 10.18240/ijo.2018.03.22. 2018
Temporal artery biopsy.
Suelves AM, España Gregori E, Díaz-Llopis M
Letter. 10.1016/j.ophtha.2013.08.023. 2013
The Brain Resting-State Functional Connectivity Underlying Violence Proneness: Is It a Reliable Marker for Neurocriminology? A Systematic Review
Romero-Martinez, A; (...); Moya-Albiol, L
Review. 10.3390/bs9010011. 2019
The effect of intravenous immunoglobulin on neuromyelitis optica.
Magraner MJ, Coret F, Casanova B
Article. 10.1016/j.nrl.2012.03.014. 2013
The Gut Metagenome Changes in Parallel to Waist Circumference, Brain Iron Deposition, and Cognitive Function
Blasco, G; (...); Fernandez-Real, JM
Article. 10.1210/jc.2017-00133. 2017
The impact of stigma in people with primary progressive multiple sclerosis
Perez-Miralles, F; (...); Casanova-Estruch, B
Meeting Abstract. 2018
The relationship between inflammatory activity and brain atrophy in natalizumab treated patients.
Magraner M, Coret F, Casanova B
Article. 10.1016/j.ejrad.2012.01.028. 2012
Therapeutic plasma exchange: applications in neurology
Lainez-Andres, Jose M.; (...); Santonja, Jose M.
Article. 10.33588/rn.6003.2014393. 2015
Tissue iron quantification in chronic liver diseases using MRI shows a relationship between iron accumulation in liver, spleen, and bone marrow
Franca, M; (...); Pessegueiro Miranda, H.
Article. 10.1016/j.crad.2017.07.022. 2018
Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
Pascual-Camps I; (...); Espana-Gregori E
Article. 10.1080/01676830.2018.1435694. 2018
Toxicity to intravitreal melphalan in a patient with retinoblastoma.
Solaz-Ruiz, Marta Gema; (...); Espana-Gregori, Enrique
Case Reports. 10.22336/rjo.2023.49. 2023
Treatment of multiple sclerosis with Rituximab: a multicenter Spanish experience
Alcala, C.; (...); Casanova, B.
Meeting Abstract. 2021
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
Gascon-Gimenez, Francisco; (...); Casanova, Bonaventura
Article. 10.3389/fneur.2023.1060696. 2023
Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.
Landete, Lamberto; (...); Casanova, Bonaventura
Article. 10.3389/fneur.2021.727586. 2021
Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice
Alcala-Vicente, C; (...); Casanova-Estruch, B
Article. 10.33588/rn.6410.2016359. 2017
Treatment with alemtuzumab after fingolimod in relapsing-remitting multiple sclerosis is effective and safe
Alcala, C; (...); Casanova, B
Meeting Abstract. 2018
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe
Alcala, C; (...); Casanova, B
Article. 10.1007/s00415-019-09195-2. 2019
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients
García-Robles AA; (...); Poveda JL
Letter. 10.1016/j.jns.2016.04.048. 2016
Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR).
deSouza NM; (...); European Society of Radiology
Article. 10.1186/s13244-019-0764-0. 2019
Validation Of A Novel Software For Correcting Distortion In Cranial Magnetic Resonance (Mr) Images
Ortega, JFC; (...); Casals, J
Meeting Abstract. 2018
Variations of OCT measurements corrected for the magnification effect according to axial length and refractive error in children
Bueno-Gimeno, I; (...); Zapata-Rodriguez, CJ
Article. 10.1142/S1793545818500013. 2018
Visual quality with corneo-scleral contact lenses after intracorneal ring segment (ICRS) implantation for keratoconus management
Montalt, JC; (...); Peris-Martinez, C
Article. 10.1016/j.clae.2018.07.006. 2019
Visual quality with corneo-scleral contact lenses for keratoconus management
Montalt, JC; (...); Peris-Martinez, C
Article. 10.1016/j.clae.2018.01.002. 2018
WHAT ARE THE MAIN BRAIN CHANGES IN FMRI AFTER TREATMENT IN FIRST EPISODE PSYCHOSIS? A SYSTEMATIC REVIEW
Gonzalez, C; (...); Sanjuan, J
Meeting Abstract. 10.1093/schbul/sby017.676. 2018
Xantogranuloma necrobiotico. Diagnostico diferencial, tratamiento e implicaciones sistemicas. A proposito de un caso.
Sanz-Marco E; (...); Diaz-Llopis M
Abstract of Published Item. 10.1016/j.oftal.2012.11.007. 2014
Zeus, the look through the anophthalmic cavity.
Placinta IA; (...); España-Gregori E
Article. 10.1016/j.oftal.2019.01.011. 2019
Estudi Clínic, Neuropsicològic I De Ressonància Magnètica De L´esclerosi Múltiple Primària Progressiva
Tesis Doctoral
Director/es: BONAVENTURA CASANOVA ESTRUCH
Estudio De La Afectación Medular En La Esclerosis Múltiple. Establecimiento De Patrones De Lesión En Neuroimagen Y Su Relación Con La Discapacidad
Tesis Doctoral
Director/es: BONAVENTURA CASANOVA ESTRUCH